Meet Our Industry Supporters

Elevate Healthcare delivers simulation training solutions to hospitals, physicians, nurses, students, emergency responders and the military in 80 countries around the world.  With a mission to improve patient safety and outcomes, Elevate Healthcare develops each product in partnership with clinicians and clinical educators whose aim is to ensure physiological accuracy and educational relevance.  Today, Elevate Healthcare offers turnkey solutions and services as well as the broadest spectrum of medical simulation products on the market.

Edwards Lifesciences’ Critical Care is now part of BD. We are advancing the world of health^TM with our hemodynamic monitoring solutions that provide real-time data and insights that enhance decision making across a range of clinical situations.

Heron’s mission is to improve patient’s lives by developing best-in-class medicines that address major unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to proven pharmacological agents. Our portfolio includes SUSTOL® (granisetron) and CINVANTITM (aprepitant), as well as one product in development; HTX-011, a novel fixed-dose combination of the local anesthetic bupivacaine with the nonsteroidal anti-inflammatory drug (NSAID) meloxicam being investigated for application into the surgical site to reduce postoperative pain and the need for opioid analgesics for 72 hours.

Masimo is a global medical technology company that produces industry-leading monitoring technologies, including innovative measurements, sensors, and patient monitors. Our mission is to improve patient outcomes, reduce the cost of care, take noninvasive monitoring to new sites and applications, and improve life.  Masimo rainbow SET^® Pulse CO-Oximetry allows accurate noninvasive, continuous monitoring in challenging conditions like motion and low perfusion, and of blood constituents that previously could only be measured invasively. Powered by Masimo Hospital Automation™ and AI-driven algorithms, Masimo connectivity, automation, and telehealth solutions improve and automate care delivery both in the hospital and the home.

Medtronic plc (www.medtronic.com), is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing non-opioid options to as many patients as possible to redefine the role of opioids as rescue therapy only. Pacira has three commercial-stage non-opioid options for treating pain: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, visit www.pacira.com.

Vertex, a global biotechnology company, invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia and continues to advance its research in these diseases. Vertex has a broad and deep clinical pipeline across a range of modalities for other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.

To learn more about ASA’s Industry and Corporate Support programs, please visit the Partner With Purpose website.